BBIO icon

BridgeBio Pharma
BBIO

Overview Fund Activity

302 hedge funds and large institutions have $6.41B invested in BridgeBio Pharma in 2025 Q1 according to their latest regulatory filings, with 74 funds opening new positions, 119 increasing their positions, 78 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
302
Holders Change
+40
Holders Change %
+15.27%
% of All Funds
4.1%
Holding in Top 10
18
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+20%
% of All Funds
0.24%
New
74
Increased
119
Reduced
78
Closed
30
Calls
$472M
Puts
$80.1M
Net Calls
+$392M
Net Calls Change
+$79.7M

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$79.5M
2
DTC
Deep Track Capital
Connecticut
+$68.5M
3
Citadel Advisors
Citadel Advisors
Florida
+$57.9M
4
FCM
Farallon Capital Management
California
+$53.1M
5
DCM
Driehaus Capital Management
Illinois
+$51.9M

Top Sellers

1
KKRC
Kohlberg Kravis Roberts & Co
New York
-$207M
2
Viking Global Investors
Viking Global Investors
Connecticut
-$106M
3
HA
HHLR Advisors
Cayman Islands
-$28.1M
4
LCM
Laurion Capital Management
New York
-$26.4M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$25.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
CWM
76
Congress Wealth Management
Massachusetts
$9.42M +$9.42M +272,506 New
WCM Investment Management
77
WCM Investment Management
California
$9.06M -$135K -3,842 -1%
SFI
78
Susquehanna Fundamental Investments
Pennsylvania
$8.77M +$546K +15,800 +7%
Nomura Holdings
79
Nomura Holdings
Japan
$8.32M +$923K +26,686 +12%
Millennium Management
80
Millennium Management
New York
$8.29M +$4.45M +128,849 +116%
Swiss National Bank
81
Swiss National Bank
Switzerland
$8.23M -$79.5K -2,300 -1%
HighTower Advisors
82
HighTower Advisors
Illinois
$7.89M -$6.81K -197 -0.1%
RhumbLine Advisers
83
RhumbLine Advisers
Massachusetts
$7.61M +$34.8K +1,008 +0.5%
Russell Investments Group
84
Russell Investments Group
United Kingdom
$7.49M +$7.35M +212,630 +5,219%
SC
85
Stempoint Capital
New York
$7.21M +$7.21M +208,437 New
Rafferty Asset Management
86
Rafferty Asset Management
New York
$6.99M -$1.66M -48,114 -19%
Point72 Asset Management
87
Point72 Asset Management
Connecticut
$6.87M +$6.87M +198,780 New
RA
88
Royce & Associates
New York
$6.63M +$1.62M +46,994 +32%
SCM
89
Superstring Capital Management
New York
$6.36M -$2.7M -78,219 -30%
JPMorgan Chase & Co
90
JPMorgan Chase & Co
New York
$6.05M -$4.29M -124,164 -41%
MIM
91
Monashee Investment Management
Massachusetts
$6.05M +$6.05M +175,000 New
NIP
92
Nicholas Investment Partners
California
$5.76M +$3.69M +106,763 +178%
EAM
93
Exome Asset Management
New York
$5.72M -$2.81M -81,204 -33%
Universal-Beteiligungs- und Servicegesellschaft
94
Universal-Beteiligungs- und Servicegesellschaft
Germany
$5.67M +$5.67M +164,061 New
HP
95
HealthInvest Partners
Sweden
$5.23M +$1.67M +48,316 +47%
Hudson Bay Capital Management
96
Hudson Bay Capital Management
Connecticut
$5.19M +$1.3M +37,465 +33%
NIM
97
NEOS Investment Management
Connecticut
$5.15M +$247K +7,145 +5%
TE
98
Tema ETFs
New York
$5.15M +$247K +7,145 +5%
EAM
99
Erste Asset Management
Austria
$4.92M – – –
PSC
100
Portman Square Capital
United Kingdom
$4.81M +$3.97M +114,720 +468%
2 3
4
5 6